Matches in Nanopublications for { ?s ?p "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.
- NP388309.RAuFxxzoljqNQodlQkaa8NnBeIWQrERXtmBmcTll3k1Lw130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388309.RAuFxxzoljqNQodlQkaa8NnBeIWQrERXtmBmcTll3k1Lw130_provenance.
- NP608603.RAkhBG4syml99CDDNp2PO9qaniB-Sy8yVkZw2UwvPnC4I130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608603.RAkhBG4syml99CDDNp2PO9qaniB-Sy8yVkZw2UwvPnC4I130_provenance.
- NP11657.RAZB-QflRbZ6PJrYmf43Ywuc_R82sCcqwkahaXoUch0z8130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11657.RAZB-QflRbZ6PJrYmf43Ywuc_R82sCcqwkahaXoUch0z8130_provenance.
- NP11656.RAtCU_U_tpOPD96M1LIwamGiJwmn_nxLppHMZeX6gc_xM130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11656.RAtCU_U_tpOPD96M1LIwamGiJwmn_nxLppHMZeX6gc_xM130_provenance.
- NP335941.RACh0OYJolJR8BPdgUjiJuJWBqwXzD65Cmq7gJnf0u3Mc130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335941.RACh0OYJolJR8BPdgUjiJuJWBqwXzD65Cmq7gJnf0u3Mc130_provenance.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.
- NP596470.RAncbK_cdICej9UfcIR9pSPu61jCKwoVp-eBUxk55eNlU130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596470.RAncbK_cdICej9UfcIR9pSPu61jCKwoVp-eBUxk55eNlU130_provenance.